Bluejay Diagnostics Files S-1/A Amendment

TL;DR

Bluejay Diagnostics filed an S-1/A, getting closer to IPO. Investors, check the details.

AI Summary

Bluejay Diagnostics, Inc. filed an S-1/A amendment on June 24, 2024, for its initial public offering. The company, incorporated in Delaware, is seeking to register an unspecified number of shares. The filing provides updated information for potential investors regarding its business, financial condition, and the terms of the offering.

Why It Matters

This S-1/A filing is a crucial step for Bluejay Diagnostics as it moves closer to becoming a publicly traded company, allowing investors to assess its potential and the risks involved.

Risk Assessment

Risk Level: medium — As a company undergoing an IPO, there are inherent risks associated with its business model, market position, and financial projections that are still being evaluated.

Key Numbers

• 3841 — SIC Code (Industry classification for Surgical & Medical Instruments & Apparatus)
• 473552922 — IRS Number (Employer Identification Number)

Key Players & Entities

• Bluejay Diagnostics, Inc. (company) — Registrant
• June 24, 2024 (date) — Filing Date
• 333-280253 (registration_number) — SEC File Number
• 360 Massachusetts Avenue, Suite 203 Acton, MA 01720 (address) — Principal Executive Offices
• Neil Dey (person) — Agent for Service

FAQ

Key Financial Figures

• $0.0001 — ne share of our common stock, par value $0.0001 per share (the “common stock&rdqu
• $3 — public offering price for each Unit is $3.01, which was the last reported sale pr
• $3.01 — (defined below) at an exercise price of $3.01 (assuming an offering price of $3.01 pe
• $0 — luding one share of common stock, minus $0.0001, and the remaining exercise price
• $75,000 — -accountable expense allowance equal to $75,000. See “Underwriting” for a d

Filing Documents

• ea0208347-s1a1_bluejay.htm (S-1/A) — 565KB
• ea020834701ex4-12_bluejay.htm (EX-4.12) — 135KB
• ea020834701ex4-13_bluejay.htm (EX-4.13) — 116KB
• ea020834701ex5-1_bluejay.htm (EX-5.1) — 13KB
• ea020834701ex23-1_bluejay.htm (EX-23.1) — 2KB
• image_001.jpg (GRAPHIC) — 4KB
• ex5-1_001.jpg (GRAPHIC) — 2KB
• 0001213900-24-055293.txt ( ) — 843KB

UNDERWRITING

UNDERWRITING 29 LEGAL MATTERS 33 EXPERTS 33 INFORMATION INCORPORATED BY REFERENCE 33 WHERE YOU CAN FIND ADDITIONAL INFORMATION 34 i ABOUT THIS PROSPECTUS The registration statement of which this prospectus forms a part that we filed with the Securities and Exchange Commission (the “SEC”) includes exhibits that provide more detail of the matters discussed in this prospectus. You should read this prospectus and the related exhibits filed with the SEC, together with the additional information described under the headings “Where You Can Find Additional Information” and “Information Incorporated by Reference” before making your investment decision. You should rely only on the information provided in or incorporated by reference in this prospectus, in any prospectus supplement or in a related free writing prospectus, or documents to which we otherwise refer you. In addition, this prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. This prospectus includes important information about us, the securities being offered and other information you should know before investing in our securities. You should not assume that the information contained in this prospectus is accurate on any date subsequent to the date set forth on the front cover of this prospectus, even though this prospectus is delivered or securities are sold or otherwise disposed of on a later date. It is important for you to read and consider all information contained in this prospectus in making your investment decision. All of the summaries in this prospectus are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a part, and you may obtain copies